Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Berg

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 23, 2011
Phosphopeptides with improved cellular uptake properties as ligands for the polo-box domain of polo-like kinase 1Susan Richter, Ines Neundorf, Kristin Loebner, et al.
ACS Chemical Biology|March 6, 2019
The STAT5b Linker Domain Mediates the Selectivity of Catechol Bisphosphates for STAT5b over STAT5aJulian Gräb, Angela Berg, Linda Blechschmidt, et al.
The American Journal of Pathology|August 16, 2011
Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivoJuping Yuan, Mourad Sanhaji, Andrea Krämer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2002
Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblastsThorsten Berg, Steven B Cohen, Joel Desharnais, et al.
Nature Chemical Biology|July 19, 2011
Serendipitous alkylation of a Plk1 ligand uncovers a new binding channelFa Liu, Jung-Eun Park, Wen-Jian Qian, et al.
Chembiochem : a European Journal of Chemical Biology|May 10, 2012
Peptoid-Peptide hybrid ligands targeting the polo box domain of polo-like kinase 1Fa Liu, Jung-Eun Park, Wen-Jian Qian, et al.
Scientific Reports|December 14, 2017
Development of Erasin: a chromone-based STAT3 inhibitor which induces apoptosis in Erlotinib-resistant lung cancer cellsChristian Lis, Stefan Rubner, Martin Roatsch, et al.
ACS Chemical Biology|February 2, 2012
Identification of high affinity polo-like kinase 1 (Plk1) polo-box domain binding peptides using oxime-based diversificationFa Liu, Jung-Eun Park, Wen-Jian Qian, et al.
Acta Pharmaceutica Sinica. B|October 26, 2019
MCC1019, a selective inhibitor of the Polo-box domain of Polo-like kinase 1 as novel, potent anticancer candidateSara Abdelfatah, Angela Berg, Qi Huang, et al.
ACS Chemical Biology|August 18, 2015
Optimized Plk1 PBD Inhibitors Based on Poloxin Induce Mitotic Arrest and Apoptosis in Tumor CellsAndrej Scharow, Monika Raab, Krishna Saxena, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|July 23, 2011
Phosphopeptides with improved cellular uptake properties as ligands for the polo-box domain of polo-like kinase 1Susan Richter, Ines Neundorf, Kristin Loebner, et al.
ACS Chemical Biology|March 6, 2019
The STAT5b Linker Domain Mediates the Selectivity of Catechol Bisphosphates for STAT5b over STAT5aJulian Gräb, Angela Berg, Linda Blechschmidt, et al.
The American Journal of Pathology|August 16, 2011
Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivoJuping Yuan, Mourad Sanhaji, Andrea Krämer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2002
Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblastsThorsten Berg, Steven B Cohen, Joel Desharnais, et al.
Nature Chemical Biology|July 19, 2011
Serendipitous alkylation of a Plk1 ligand uncovers a new binding channelFa Liu, Jung-Eun Park, Wen-Jian Qian, et al.
Chembiochem : a European Journal of Chemical Biology|May 10, 2012
Peptoid-Peptide hybrid ligands targeting the polo box domain of polo-like kinase 1Fa Liu, Jung-Eun Park, Wen-Jian Qian, et al.
Scientific Reports|December 14, 2017
Development of Erasin: a chromone-based STAT3 inhibitor which induces apoptosis in Erlotinib-resistant lung cancer cellsChristian Lis, Stefan Rubner, Martin Roatsch, et al.
ACS Chemical Biology|February 2, 2012
Identification of high affinity polo-like kinase 1 (Plk1) polo-box domain binding peptides using oxime-based diversificationFa Liu, Jung-Eun Park, Wen-Jian Qian, et al.
Acta Pharmaceutica Sinica. B|October 26, 2019
MCC1019, a selective inhibitor of the Polo-box domain of Polo-like kinase 1 as novel, potent anticancer candidateSara Abdelfatah, Angela Berg, Qi Huang, et al.
ACS Chemical Biology|August 18, 2015
Optimized Plk1 PBD Inhibitors Based on Poloxin Induce Mitotic Arrest and Apoptosis in Tumor CellsAndrej Scharow, Monika Raab, Krishna Saxena, et al.
Pageof 8